KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to 22.61%.

  • Medpace Holdings' EBITDA Margin fell 20900.0% to 22.61% in Q4 2025 from the same period last year, while for Dec 2025 it was 22.22%, marking a year-over-year decrease of 2900.0%. This contributed to the annual value of 22.22% for FY2025, which is 2900.0% down from last year.
  • Medpace Holdings' EBITDA Margin amounted to 22.61% in Q4 2025, which was down 20900.0% from 22.52% recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' EBITDA Margin peaked at 24.7% during Q4 2024, and registered a low of 16.67% during Q2 2021.
  • In the last 5 years, Medpace Holdings' EBITDA Margin had a median value of 20.9% in 2022 and averaged 20.6%.
  • As far as peak fluctuations go, Medpace Holdings' EBITDA Margin plummeted by -34200bps in 2021, and later soared by 58900bps in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' EBITDA Margin stood at 19.13% in 2021, then increased by 8bps to 20.68% in 2022, then fell by -9bps to 18.81% in 2023, then skyrocketed by 31bps to 24.7% in 2024, then fell by -8bps to 22.61% in 2025.
  • Its last three reported values are 22.61% in Q4 2025, 22.52% for Q3 2025, and 22.06% during Q2 2025.